TVARDI THERAPEUTICS, INC. Noncash Merger Related Costs
TVARDI THERAPEUTICS, INC. (TVRD) reported Noncash Merger Related Costs of $429.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashMergerRelatedCosts · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. noncash merger related costs for the quarter ending 2025-06-30 was -$352.00K.
- TVARDI THERAPEUTICS, INC. noncash merger related costs for the quarter ending 2025-03-31 was $781.00K.
- TVARDI THERAPEUTICS, INC. noncash merger related costs for the quarter ending 2024-12-31 was $439.00K.
- TVARDI THERAPEUTICS, INC. noncash merger related costs for fiscal 2024 was $1.51M.
| Period end | Noncash Merger Related Costs 3 month | Noncash Merger Related Costs 6 month | Noncash Merger Related Costs 9 month | Noncash Merger Related Costs 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $429.00K 10-Q · filed 2026-08-14 | $868.00K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-03-31 | $781.00K 10-Q · filed 2026-05-08 | $1.22M derived: sum of 2 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.51M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $1.07M 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |